ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sublimity hires new CMO as it advances UC candidate in phase 2
fiercebiotech
August 01, 2018Ulcerative colitis specialist Sublimity Therapeutics brought on Jesse Hall, M.D., to be its new chief medical officer, as the company looks to advance the clinical development of its lead candidate into a phase 2b study.
Pharma Sources Insight January 2025
